|
| 36729133 | Associations of psychiatric disease and ageing with FKBP5 expression converge on superficial layer neurons of the neocortex. | Acta Neuropathol | 2023 |
| 37722808 | Common changes in rat cortical gene expression after valproate or lithium treatment particularly affect pre- and post-synaptic pathways that regulate four neurotransmitters systems. | | 2023 |
| 38071879 | Lower levels of soluble β-amyloid precursor protein, but not β-amyloid, in the frontal cortex in schizophrenia. | | 2023 |
| 37079947 | Lower levels of cortical [H]pirenzepine binding to postmortem tissue defines a sub-group of older people with schizophrenia with less severe cognitive deficits. | | 2023 |
| 36252418 | Evidence that a working memory cognitive phenotype within schizophrenia has a unique underlying biology. | Psychiatry Research | 2022 |
| 34521861 | Changes in cortical gene expression in the muscarinic M1 receptor knockout mouse: potential relevance to schizophrenia, Alzheimer's disease and cognition. | Schizophrenia | 2021 |
| 33639407 | Cortical expression of the RAPGEF1 gene in schizophrenia: investigating regional differences and suicide. | Psychiatry Research | 2021 |
| 29956574 | The use of a gene expression signature and connectivity map to repurpose drugs for bipolar disorder. | World J Biol Psychiatry | 2020 |
| 32315882 | Muscarinic M1 and M4 receptors: Hypothesis driven drug development for schizophrenia. | Psychiatry Research | 2020 |
| 32507381 | Higher levels of α7 nicotinic receptors, but not choline acetyltransferase, in the dorsolateral prefrontal cortex from a sub-group of patients with schizophrenia. | Schizophrenia Research | 2020 |
| 30513246 | Changes in cortical protein markers of iron transport with gender, major depressive disorder and suicide. | World Journal of Biological Psychiatry | 2020 |
| 31238704 | Changed cortical risk gene expression in major depression and shared changes in cortical gene expression between major depression and bipolar disorders. | Australian and New Zealand Journal of Psychiatry | 2019 |
| 30292148 | Cortical biometals: Changed levels in suicide and with mood disorders. | Journal of Affective Disorders | 2019 |
| 27801890 | Changed gene expression in subjects with schizophrenia and low cortical muscarinic M1 receptors predicts disrupted upstream pathways interacting with that receptor. | Molecular Psychiatry | 2018 |
| 30218069 | Catechol-O-methyltransferase (COMT) genotypes are associated with varying soluble, but not membrane-bound COMT protein in the human prefrontal cortex. | Journal of Human Genetics | 2018 |
| 30052978 | Studies on Prostaglandin-Endoperoxide Synthase 1: Lower Levels in Schizophrenia and After Treatment with Antipsychotic Drugs in Conjunction with Aspirin. | International Journal of Neuropsychopharmacology | 2018 |
| 30125244 | Low levels of muscarinic M1 receptor-positive neurons in cortical layers III and V in Brodmann areas 9 and 17 from individuals with schizophrenia. | Journal of Psychiatry and Neuroscience | 2018 |
| 29463818 | Changed frontal pole gene expression suggest altered interplay between neurotransmitter, developmental, and inflammatory pathways in schizophrenia. | Schizophrenia | 2018 |
| 29848411 | Low levels of muscarinic M1 receptor-positive neurons in cortical layers III and V in Brodmann areas 9 and 17 from individuals with schizophrenia. | Journal of Psychiatry and Neuroscience | 2018 |
| 27873015 | Muscarinic receptor binding changes in postmortem Parkinson's disease. | Journal of Neural Transmission | 2017 |
| 28560265 | Isoform specific differences in phospholipase C beta 1 expression in the prefrontal cortex in schizophrenia and suicide. | Schizophrenia | 2017 |
| 27688247 | Higher levels of different muscarinic receptors in the cortex and hippocampus from subjects with Alzheimer's disease. | Journal of Neural Transmission | 2017 |
| 27845781 | Evidence for impaired glucose metabolism in the striatum, obtained postmortem, from some subjects with schizophrenia. | Translational Psychiatry | 2016 |
| 27435807 | The distribution of muscarinic M1 receptors in the human hippocampus. | Journal of Chemical Neuroanatomy | 2016 |
| 27014601 | Biomarkers in schizophrenia: A focus on blood based diagnostics and theranostics. | | 2016 |
| 27336053 | Increased cortical expression of the zinc transporter SLC39A12 suggests a breakdown in zinc cellular homeostasis as part of the pathophysiology of schizophrenia. | Schizophrenia | 2016 |
| 27184458 | Understanding the pathophysiology of schizophrenia: Contributions from the Melbourne Psychiatric Brain Bank. | Schizophrenia Research | 2016 |
| 26954460 | COMT genotype is associated with differential expression of muscarinic M1 receptors in human cortex. | American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics | 2016 |
| 26784971 | Aberrant expression of microRNAs as biomarker for schizophrenia: from acute state to partial remission, and from peripheral blood to cortical tissue. | Translational Psychiatry | 2016 |
| 27206773 | Validating reference genes using minimally transformed qpcr data: findings in human cortex and outcomes in schizophrenia. | BMC Psychiatry | 2016 |
| 26013316 | Changes in cortical N-methyl-D-aspartate receptors and post-synaptic density protein 95 in schizophrenia, mood disorders and suicide. | Australian and New Zealand Journal of Psychiatry | 2016 |
| 26521087 | Lower [3H]LY341495 binding to mGlu2/3 receptors in the anterior cingulate of subjects with major depressive disorder but not bipolar disorder or schizophrenia. | Journal of Affective Disorders | 2016 |
| 26475745 | Changes in Muscarinic M2 Receptor Levels in the Cortex of Subjects with Bipolar Disorder and Major Depressive Disorder and in Rats after Treatment with Mood Stabilisers and Antidepressants. | International Journal of Neuropsychopharmacology | 2016 |
| 26511338 | Changes in BQCA Allosteric Modulation of [(3)H]NMS Binding to Human Cortex within Schizophrenia and by Divalent Cations. | | 2016 |
| 24365867 | Autophagy has a key role in the pathophysiology of schizophrenia. | Molecular Psychiatry | 2015 |
| 25817858 | Possible involvement of muscarinic receptors in psychiatric disorders: a focus on schizophrenia and mood disorders. | Current Molecular Medicine | 2015 |
| 25899066 | Biomarkers for Psychiatry: The Journey from Fantasy to Fact, a Report of the 2013 CINP Think Tank. | International Journal of Neuropsychopharmacology | 2015 |
| 26481978 | The effect of a muscarinic receptor 1 gene variant on grey matter volume in schizophrenia. | Psychiatry Research | 2015 |
| 26545297 | Changes in cholinergic and glutamatergic markers in the striatum from a sub-set of subjects with schizophrenia. | Schizophrenia Research | 2015 |
| 26630954 | The Role of Muscarinic Receptors in the Pathophysiology of Mood Disorders: A Potential Novel Treatment? | Current Neuropharmacology | 2015 |
| 26241353 | SELENBP1 expression in the prefrontal cortex of subjects with schizophrenia. | Translational Psychiatry | 2015 |
| 24703170 | A four week randomised control trial of adjunctive medroxyprogesterone and tamoxifen in women with mania. | Psychoneuroendocrinology | 2014 |
| 24063634 | Problems and solutions to filling the drying drug pipeline for psychiatric disorders: a report from the inaugural 2012 CINP Think Tank. | Int J Neuropsychopharmacol | 2014 |
| 24495390 | Lower cortical serotonin 2A receptors in major depressive disorder, suicide and in rats after administration of imipramine. | International Journal of Neuropsychopharmacology | 2014 |
| 25037527 | An investigation of the factors that regulate muscarinic receptor expression in schizophrenia. | Schizophrenia Research | 2014 |
| 25191500 | Potential molecular and cellular mechanism of psychotropic drugs. | Clinical Psychopharmacology and Neuroscience | 2014 |
| 23067681 | Muscarinic M1 receptor agonists: can they improve cognitive performance? | International Journal of Neuropsychopharmacology | 2013 |
| 22801413 | Different changes in cortical tumor necrosis factor-α-related pathways in schizophrenia and mood disorders. | Molecular Psychiatry | 2013 |
| 22338582 | Widespread decreases in cortical muscarinic receptors in a subset of people with schizophrenia. | International Journal of Neuropsychopharmacology | 2013 |
| 23490763 | Cholinergic muscarinic M4 receptor gene polymorphisms: a potential risk factor and pharmacogenomic marker for schizophrenia. | Schizophrenia Research | 2013 |